How much funding has NED Medical raised?

NED Medical has disclosed $8.5M raised across 2 rounds.

Where is NED Medical headquartered?

NED Medical is headquartered in Norwell, US.

NED Medical

Norwell, US · Founded 2022 · Delaware corporation

Find your way into NED Medical

Paths you didn't know you had: your email and LinkedIn already hold routes to the NED Medical team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

NED Medical develops CombiSphere, a Y90 radioembolization therapy made with proprietary materials offering optimized particle size, density, radiopacity, and dosimetry to treat liver cancer. The product is aimed at clinicians treating oncology patients through embolization therapy.

Biotech Healthtech Medical Devices

Founders & leadership

Richard Yazbeck President & CEO, Co-founderExecutive Officer and Director at NED Medical, which develops CombiSphere, a radioembolization therapy for liver cancer treatment. He brings experience in medical device product development and team leadership across commercialization phases.

Andrew ThoresonNamed on SEC filing

Board

Robert Matthew NiblackBoard director

David UfferBoard director

James MitchellBoard director

Gregory J KapustBoard director

Reported raises · per SEC filings

Form D private placements

$8.5M disclosed across 2 rounds · 2023–2026

▶$8MraisedFeb 2026 · 3 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Robert Matthew NiblackDirector
David UfferDirector
James MitchellDirector
Richard YazbeckExecutive Officer, Director
Gregory J KapustDirector

Offering amount: $11M
Amount sold: $8M
First sale: Jan 2026
Incorporated: Corporation, Delaware, 2022
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$500KraisedAug 2023 · 2 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Richard YazbeckDirector
Robert Matthew NiblackDirector
David UfferDirector
Andrew ThoresonDirector

Offering amount: $1.8M
Amount sold: $500K
First sale: Aug 2023
Incorporated: Corporation, Delaware, 2022
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

CqmedicalCQ Medical develops patient positioning and immobilization products used in radiation therapy, including devices for brachytherapy, SBRT, SRS, and proton treatments. Its offerings serve oncology and radiotherapy clinicians treating cancer and conditions such as osteoarthritis.

Companies working in the same space as NED Medical.

In the news

NED Medical has filed a notice of an exempt offering of securities to raise $11 Million in New Funding. - intelligence360intelligence360.news · Mar 2026

Frequently asked questions

What does NED Medical do?: NED Medical develops CombiSphere, a Y90 radioembolization therapy made with proprietary materials offering optimized particle size, density, radiopacity, and dosimetry to treat liver cancer. The product is aimed at clinicians treating oncology patients through embolization therapy.
How much funding has NED Medical raised?: NED Medical has disclosed $8.5M raised across 2 rounds.
Where is NED Medical headquartered?: NED Medical is headquartered in Norwell, US.